Broker valuation summaryRCR: 0.61 14/4/2010 Stonebridge: 0.60 14/10/2009Hartleys: 0.69 17/9/2009Fat Prophets: 0.54 15/4/2010Note: Fat Prophets target based on TA.DYOR
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution